Article: Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients.
Full Text (publisher's website) ;
Article Metadata ;
Article Data (extracted)
Bergenfelz C; Larsson AM; von Stedingk K; Gruvberger-Saal S; Aaltonen K; Jansson S; Jernström H; Janols H; Wullt M; Bredberg A; Rydén L; Leandersson K
PLoS ONE, 2015
10.1371/journal.pone.0127028.t002
Correlations between clinical parameters of patients with LRR/MBC and”normal” or”high” frequency of Mo-MDSCs of PBMCs (see Fig 3A).
|
|
”Normal” Mo-MDSC |
”High” Mo-MDSC |
P-value |
Mean age |
|
62 ± 10 y |
58 ± 10 y |
0.3 |
Tumor type |
Ductal |
11 |
10 |
0.99 |
Lobular |
1 |
1 |
|
Other |
1 |
1 |
|
NHG |
1 |
1 |
0 |
0.41 |
2 |
5 |
4 |
|
3 |
5 |
1 |
|
Unknown |
2 |
7 |
|
Tumor Size (T) |
T1 |
4 |
3 |
0.72 |
T2 |
5 |
2 |
|
T3 |
1 |
2 |
|
T4 |
1 |
1 |
|
Unknown |
2 |
4 |
|
Node status (N) |
N0 |
5 |
2 |
0.22 |
N1 |
4 |
1 |
|
N2 |
2 |
4 |
|
Unknown |
2 |
5 |
|
Hormone Receptor Status |
ER+ |
11 |
5 |
0.07 |
ER- |
2 |
5 |
|
Unknown |
0 |
2 |
|
PR+ |
8 |
6 |
0.94 |
PR- |
5 |
4 |
|
Unknown |
0 |
2 |
|
HER2 status |
HER2+ |
2 |
3 |
0.41 |
HER2- |
8 |
5 |
|
Unknown |
3 |
4 |
|
Adjuvant chemotherapy |
Yes |
4 |
3 |
0.75 |
No |
9 |
9 |
|
Type of recurrence |
Locoregional recurrence |
2 |
0 |
0.04 |
|
Distant recurrence |
10 |
6 |
|
|
Distant metastasis at initial diagnosis |
1 |
6 |
|
Number of metastatic sites |
0-2 |
9 |
4 |
0.07 |
|
3-5 |
4 |
8 |
|
Metastatic site |
Lymph nodes |
2 |
8 |
0.009 |
Lung |
4 |
4 |
0.9 |
Liver |
2 |
6 |
0.06 |
Bone |
9 |
11 |
0.16 |
Visceral |
5 |
9 |
0.07 |
Bone-only |
5 |
1 |
0.08 |
Time to recurrence |
|
51 ± 50 m |
52 ± 75 m |
0.57 |
Inferred neuron-electrophysiology data values
Neuron Type |
Neuron Description |
Ephys Prop |
Extracted Value |
Standardized Value |
Content Source |